US Stock MarketDetailed Quotes

EW Edwards Lifesciences

Watchlist
  • 76.190
  • +0.190+0.25%
Close Feb 14 16:00 ET
  • 76.190
  • 0.0000.00%
Post 20:01 ET
44.94BMarket Cap10.93P/E (TTM)

About Edwards Lifesciences Company

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Company Profile

SymbolEW
Company NameEdwards Lifesciences
Listing DateMar 27, 2000
Founded1958
CEOMr. Bernard J. Zovighian
MarketNYSE
Employees19800
Fiscal Year Ends12-31
Address1 Edwards Way
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92614
Phone1-949-250-2500

Company Executives

  • Name
  • Position
  • Salary
  • Bernard J. Zovighian
  • Director and Chief Executive Officer
  • 12.87M
  • Scott B. Ullem
  • Corporate Vice President and Chief Financial Officer
  • 5.95M
  • Wayne Markowitz
  • General Manager and Senior Vice President, Surgical Structural Heart
  • --
  • Andrew M. Dahl
  • Principal Accounting Officer, Senior Vice President and Corporate Controller
  • --
  • Donald E. Bobo,Jr
  • Corporate Vice President
  • 4.29M
  • Jean-Luc M. Lemercier
  • Corporate Vice President, Europe, Middle East, Africa, Canada and Latin America
  • --
  • Catherine M. Szyman
  • Corporate Vice President, Critical Care
  • 4.34M
  • Larry L. Wood
  • Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart
  • 5.40M
  • Daveen Chopra
  • Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies
  • --
  • Daniel J. Lippis
  • Corporate Vice President, JAPAC
  • --
  • Nicholas J. Valeriani
  • Chairman of the Board
  • 347.97K
  • Dr. David T. Feinberg, M.D.,PhD
  • Director
  • --
  • Steven R. Loranger
  • Independent Director
  • 335.06K
  • Leslie C. Davis
  • Independent Director
  • --
  • Leslie Stone Heisz
  • Independent Director
  • 356.42K
  • Paul A. Laviolette
  • Independent Director
  • 329.97K
  • Ramona Sequeira
  • Independent Director
  • 334.97K
  • Kieran T. Gallahue
  • Independent Director
  • 335.06K

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More